Cell - 医索

找到约 332 条结果

中位生存近3年！“百万”CAR-T带领淋巴瘤患者走向“治愈”

8月2日，《Journal of Clinical Oncology》发表了一篇题为"Five-Year Follow-Up of Standard-of-Care AxicabtageneCiloleucel for Large B-Cell Lymphoma: Results From the USLVnhoma CART Conso"的研究论文，文中介绍了国内CA.....

学术资讯 - 文献解读

完全消失！DC疫苗剑指胶质母细胞瘤、胰腺癌、胃癌、尿路上皮癌

7月25日，《Cancer Immunology Research》刊登了一篇题为"Machine Learning-Directed Conversion of Glioblastoma Cells to Dendritic Cell-like Antigen-Presenting Cells as Cancer Immunotherapy"的研究论.....

学术资讯 - 临床研究

Phasel study of C-CAR031, aGPc3-specificTGFBRllDN armored autologous CAR-T, inpatients with advanced hepatocellularcarcinoma(Hcc)

医客学院 - 会议报告集

Nivolumab plus ipilimumab vs lenvatinib or sorafenib asfirst-line treatment for unresectable hepatocellularcarcinoma first results from CheckMate 9DW

医客学院 - 会议报告集

International, open-label phase 2 study of regorafenibplus pembrolizumab in patients with advancedhepatocellular carcinoma previously treated withimmune checkpoint inhibitors

医客学院 - 会议报告集

Outcomes of Advanced MetastaticBreast Cancer(aMBC) Treated with Bria-lMT, an Allogeneic Whole-cell Immunotherapy

医客学院 - 会议报告集

Subcutaneous amivantamab vs intravenous amivantamabboth in combination with lazertinib, in refractoryEGFR-mutated,advanced non-small cell lung cancer

医客学院 - 会议报告集

Safety and efficacy of osimertinib plus consolidativestereotactic ablative radiation(SABR) inadvanced EGFR mutant non-small cell lungcancer(NSCLC)results from a multi-center Phase ltrial

医客学院 - 会议报告集

NRG-LU002Randomized Phase lllll Trial Of MaintenanceSystemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer

医客学院 - 会议报告集

Molecular residual disease analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage lB-lllA non-small cell lung cancer

医客学院 - 会议报告集

首页
上一页
1
2
3
4
5
...
33
34
下一页
尾页

今日实时热搜